Dr. Agarwal's Eye Hospital Merger: BSE, NSE ne di Green Signal! Ab NCLT ki baari

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorAarav Shah|Published at:
Dr. Agarwal's Eye Hospital Merger: BSE, NSE ne di Green Signal! Ab NCLT ki baari
Overview

Arre suno! Dr. Agarwal's Health Care Limited ke liye ek super important update hai. Inki Dr. Agarwal's Eye Hospital Limited ke saath jo merger ki deal chal rahi thi, usko BSE aur NSE dono ne green signal de diya hai. Toh ab company final approvals ke liye aage badhegi.

Deal ko mili regulatory approval!

Asal mein, Dr. Agarwal's Health Care Limited (AHCL) ko BSE se 'no adverse observations' aur National Stock Exchange (NSE) se 'no objection' letter mil gaya hai Dr. Agarwal's Eye Hospital Limited (AEHL) ke saath merger karne ke liye. Yeh approvals February 16-17, 2026 ko aaye hain, aur yeh deal ko aage badhane ke liye bahut zaroori the.

Deal se kya hoga fayda?

Company ka kehna hai ki is merger se operational aur financial efficiencies aayengi. Decision making tez hogi, capital manage karna aasan hoga, aur balance sheet bhi strong banegi future growth ke liye. Sabse achhi baat, yeh deal pehle saal se hi EPS accretive hogi, matlab investors ko fayda mil sakta hai.

Deal kaise hogi? AHCL, eligible AEHL shareholders ko har 2 equity shares ke badle 23 naye equity shares degi. Aur haan, AEHL ek preferential issue bhi karne wali hai lagbhag ₹70 Crore ka.

AHCL khud February 2025 mein hi list hui thi, aur unke IPO document mein bhi aisi merger explore karne ka intention tha.

Aage kya?

Abhi final approval National Company Law Tribunal (NCLT) se leni hai, saath hi shareholders aur creditors ki bhi approval chahiye. SEBI ne bhi kuch conditions di hain jinke baare mein NSE observation letter mein bataya gaya hai.

Company poori speed se expand kar rahi hai. Unka target hai 55-60 naye centres kholne ka. December 2025 tak unke 272 centres already operate kar rahe hain.

Past mein kya hua tha?

Yaad rakhna, 2013 mein Dr. Agarwal's Eye Hospital ko SEBI se public shareholding norms ko lekar issue hua tha. Uske baad promoter holding 74.90% aur public holding 25.10% ho gayi thi. Tab SEBI ne warning di thi ki future mein laws follow karein.

Market ka scene?

Indian eye care market mein kaafi competition hai. Dr. Agarwal's Health Care khud ko India ki sabse badi eye care chain batati hai revenue ke hisaab se, market share lagbhag 25% (FY24) aur sabse zyada centres ke saath. Recent Q3 FY26 mein revenue 23% YoY badha hai.

Bade competitors bhi hain jaise Centre for Sight (around 83 centers, ₹582 Crore revenue FY25) aur LV Prasad Eye Institute (300+ centers). Eye care sector mein EBITDA margins 5-10% higher hote hain, isliye yeh merger company ko market mein aur strong banayega.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.